Schedule 13D ownership disclosure

iBioPharma, Inc.

Security class unavailable · CUSIP: 45107K102

Event date: 2014-09-29

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
5,751,143
Percent of class
8.7600%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001102948-14-000008
Form type
SC 13D/A
Filer
DESANTIS CARL
CIK
CIK 1102948
Filed
Sep 29, 2014
Reporting period
Sep 29, 2014
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub